ViroFend Therapeutics receives a Salamanca Impulsa Award for its contribution to the biotech ecosystem
Since its inception, ViroFend has focused on building an organization capable of translating a highly complex biomedical technology into the clinical setting, based on internationally leading intellectual property.
ViroFend Therapeutics S.L. has been awarded one of the Salamanca Impulsa Awards granted by the Salamanca Progress Foundation, an initiative that highlights innovative business projects contributing to the strengthening of the city’s technological and scientific ecosystem.
This recognition provides an opportunity to increase the visibility of the project and the work being carried out in the field of biotechnology, within an environment that in recent years has reinforced its commitment to science, innovation, and knowledge transfer.
Since its inception, ViroFend has focused on building an organization capable of translating a highly complex biomedical technology into the clinical setting, based on internationally leading intellectual property. This process has required the design of a scientific, corporate, and financial structure aligned with high regulatory and clinical standards, as well as the incorporation of a highly qualified team and collaboration with strategic partners and specialized investors.
The project is being developed in Salamanca, supported by a growing ecosystem and first-class scientific infrastructure, demonstrating that it is possible to drive globally impactful biotech initiatives from the region. Guided by the philosophy “from Salamanca to the world,” ViroFend reaffirms its commitment to innovation, applied science, and the development of therapies with the potential to transform cancer treatment.